Novo Nordisk Wegovy Reduces Liver Fat In Obesity Without Diabetes

A post hoc analysis of data from Novo Nordisk's STEP UP trial shows that its obesity drug Wegovy reduced liver fat in adults who are obese but do not have diabetes.